Glenmark Life SciencesGLS 
$15.41-1.00%24h
-1.00%24h
Global rank5380
Market cap$1.89B
Change 7d12.42%
YTD Performance96.18%
SP500 benchmarkOutperform
P/E0.40
P/S7.74
Revenue$244.12M
Earnings$55.67M
Dividend yield-
Main Sector
Healthcare
Category
Glenmark Life Sciences (GLS) Total Liabilities
GLS Total Liabilities in 2022: $67.23M
According to Glenmark Life Sciences latest financial reports the total liabilities of GLS is $67.23M, an increase of 35.34% to 2022. At the end of 2022 company had $49.67M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Glenmark Life Sciences is responsible for during its operational activities.
Glenmark Life Sciences (GLS) Total Liabilities History from 2023 to 2022
-
Value:-
GLS Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $67.23M | 35.34% |
| 2022 | $49.67M | -66.51% |
| 2021 | $148.34M | -6.01% |
| 2020 | $157.82M | 606.41% |
| 2019 | $22.34M | - |
View the Top Total Liabilies Stocks
